February 19, 2009
Genzyme Receives Positive Opinion on Myozyme from CHMP
CAMBRIDGE, Mass. – Genzyme Corporation (Nasdaq: GENZ) announced today that the Committee for Medicinal Products for Human Use (CHMP) has
February 4, 2009
November 2008 Pompe Program Update 2
Genzyme Pompe Program Update- November 17, 2008 We would like to take this opportunity to provide an important update to
Myozyme Produced at the 2000 L Bioreactor Scale to Receive Accelerated Approval
February 4, 2009
November 2008 Pompe Program Update
Genzyme Program Update November 10th, 2008 Genzyme would like to take this opportunity to provide an update to the Pompe